Aethlon Medical FY 2024 GAAP EPS $(4.86) Beats $(5.22) Estimate
Portfolio Pulse from Benzinga Newsdesk
Aethlon Medical (NASDAQ:AEMD) reported a GAAP EPS of $(4.86) for FY 2024, beating the analyst consensus estimate of $(5.22) by 6.9%.
June 27, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aethlon Medical reported a GAAP EPS of $(4.86) for FY 2024, which is better than the analyst consensus estimate of $(5.22). This positive earnings surprise may boost investor confidence in the short term.
The reported GAAP EPS of $(4.86) is a 6.9% improvement over the expected $(5.22). Beating earnings estimates typically leads to a positive short-term impact on the stock price as it indicates better-than-expected financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100